Mode
Text Size
Log in / Sign up
N/A Completed N=699 Treatment

Women Empowered to Live With Lupus Study

Lupus Erythematosus, Systemic
Source: ClinicalTrials.gov NCT02988661 ↗
Enrolled (actual)
699
Serious AEs
Results posted
Mar 2022
Primary outcomePrimary: Communication With Physician - Stanford 3Q Scale Score — 3.1; 2.9; 3.3; 3.0 score on a scale

Summary

The purpose of this research is to examine whether the Chronic Disease Self-management Program (CDSMP) would improve health outcomes and reduce health care use in African American women with systemic lupus erythematosus (SLE). The CDSMP is a generic, evidence-based self-management education program that has been shown to help people with chronic conditions to take control of their health problems. This study focuses on African American women with SLE because the CDSMP has not been widely studied in this population.

Outcome Measures

OutcomeResultp-value
PRIMARY
Communication With Physician - Stanford 3Q Scale Score
3.1; 2.9; 3.3; 3.0; 3.3; 3.0
PRIMARY
Patient-Reported Outcome Measurement Information System (PROMIS) Self-efficacy for Managing Medications and Treatments Score
46.1; 46.1; 47.0; 47.5; 46.2; 47.0
PRIMARY
PROMIS Global Health Physical Health Domain Score
38.3; 40.6; 39.0; 40.0; 38.9; 40.3
PRIMARY
PROMIS Global Health Mental Health Domain Score
41.5; 43.5; 42.4; 43.2; 42.4; 43.4
PRIMARY
PROMIS Physical Function Score
38.4; 40.5; 38.4; 40.8; 39.0; 40.1
PRIMARY
PROMIS Pain Interference Score
59.0; 57.7; 59.1; 57.6; 59.3; 57.9
PRIMARY
PROMIS Fatigue Score
58.6; 57.6; 59.5; 57.5; 58.7; 57.8
PRIMARY
PROMIS Sleep Disturbance Score
57.3; 56.6; 57.8; 55.8; 57.3; 56.5
PRIMARY
PROMIS Anxiety Score
53.8; 52.0; 54.6; 50.5; 54.3; 52.0
PRIMARY
PROMIS Ability to Participate in Social Roles and Activities Score
45.3; 47.4; 45.0; 47.1; 45.5; 46.6
SECONDARY
Number of Participants at Each Activation Level of the Patient Activation Measure (PAM-10)
12; 40; 25; 123; 72; 206
SECONDARY
PROMIS Adult Self-Efficacy Score
47.1; 48.4; 47.5; 49.1; 48.2; 48.7
SECONDARY
PROMIS Anger Score
53.2; 51.0; 53.5; 50.3; 52.7; 50.8
SECONDARY
Perceived Stress Scale 4 (PSS-4) Score
6.2; 6.3; 6.2; 6.1; 6.0; 6.4
SECONDARY
Hospitalization Rate
42.3; 45.5; 49.6; 47.8
SECONDARY
Emergency Department Visit Rate
126.2; 121.3; 103.9; 111.5

Eligibility Criteria

Inclusion Criteria

  • Currently participating in the GOAL study

Exclusion Criteria

  • Participation in the Chronic Disease Self-Management Program (CDSMP) in the past five years
  • Significant cognitive impairment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02988661). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search